Biotech start-up backed by Li Ka-shing and Bill Gates to launch its immunity-boosting gut bacteria in Hong Kong, Singapore

A Californian probiotics developer backed by tycoons Li Ka-shing and Bill Gates will launch a dietary product it claims can strengthen infants’ immune system in Hong Kong and Singapore on Tuesday.

Evolve BioSystems said the product works by reintroducing a beneficial gut bacteria that is missing in today’s babies.

Evivo, an activated form of the intestinal bacteria Bifidobacterium infantis, has been mixed with breast milk and fed to “tens of thousands” of babies in the United States since it was launched two years ago, according to Evolve’s chief executive, Timothy Brown.

The company has chosen the two cities, among the richest in Asia, as the regional launchpads for its first foray outside its home market.

It aims to address the autoimmune health challenges that have arisen in the region in the past few decades, such as eczema and allergies, which have coincided with the rise of formula feeding, C-section deliveries and excessive use of antibiotics.